Compounds > 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol
Page last updated: 2024-10-26

1-phenyl-2-palmitoylamino-3-morpholino-1-propanol and HIV Coinfection

1-phenyl-2-palmitoylamino-3-morpholino-1-propanol has been researched along with HIV Coinfection in 1 studies

1-phenyl-2-palmitoylamino-3-morpholino-1-propanol: a sphingolipid analog; inhibits the enzyme activity in infected erythrocytes
N-[1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide : A fatty amide resulting from the formal condensation of palmitic acid with the primary amino group of 2-amino-3-(morpholin-4-yl)-1-phenylpropan-1-ol.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Puri, A1
Rawat, SS1
Lin, HM1
Finnegan, CM1
Mikovits, J1
Ruscetti, FW1
Blumenthal, R1

Other Studies

1 other study available for 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol and HIV Coinfection

ArticleYear
An inhibitor of glycosphingolipid metabolism blocks HIV-1 infection of primary T-cells.
    AIDS (London, England), 2004, Apr-09, Volume: 18, Issue:6

    Topics: CD4-Positive T-Lymphocytes; Cells, Cultured; Glycosphingolipids; HIV Core Protein p24; HIV Fusion In

2004